Mutation of PARK2 Gene in Sporadic Early-Onset Parkinson's Disease and Its Clinical Characteristics

CHEN Si,LIU Yi-ming,REN Nan-nan,CHEN Liang,LI Jia-zhen,NING Xiang,WANG Jing
DOI: https://doi.org/10.6040/j.issn.1671-7554.2012.07.012
2012-01-01
Abstract:Objective To investigate PARK2 gene mutations in 42 patients with sporadic early-onset Parkinson′s disease(EOPD) and to explore their clinical characteristics.Methods A total of 42 sporadic EOPD patients were screened for mutations in PARK2 gene by using SYBR GreenI real-time PCR and DNA direct sequencing methods.Results 5 patients carried PARK2 gene mutations in the 42 sporadic EOPD,including 1 heterozygous deletions mutation,1 homozygous duplication mutation,1compound heterozygous point mutation and 2 identical heterozygous small sequence deletion mutations.Two of the mutations(c.850GC and c.968-973delGTGTCC) were reported previously.The c.925GT was a novel mutation.The patients with PARK2 mutations showed an earlier onset age than those without PARK2 mutations.But they showed no significant difference in the score of UPDRS(Unified Parkinson′s Disease Rating Scale)3.0 and Hoehr-Yahr.Conclusion The frequency of mutations in PARK2 gene is 11.9% in sporadic EOPD.Point mutation is the main type of mutations in sporadic EOPD.There are no significant differences in clinical features and disease severiies between patients with or without PARK2 mutations.However,patients who carry PARK2 mutations show a significantly earlier onset age,longer disease duration and slower progression than those without PARK2 mutations.
What problem does this paper attempt to address?